Verlingue, L. (2024) “The French multicentric molecular analysis platforms and personalized medicine trials MOST, MOST Plus and MEGAMOST”, Acta Oncologica, 63(1), pp. 411–417. doi: 10.2340/1651-226X.2024.32745.